New toxin receives national approval in the UK
Aesthetic manufacturer Croma-Pharma has announced the national approval of its new botulinum toxin in the UK.
Aesthetic manufacturer Croma-Pharma has announced the national approval of its new botulinum toxin in the UK.
As of January 25, aesthetic manufacturer Croma-Pharma has confirmed completion of the decentralised procedure for its new botulinum toxin.
Aesthetic manufacturer Croma-Pharma has expanded its face mask range.
Aesthetic manufacturer Croma-Pharma has launched a new polynucleotide based injectable named juvenus.
Aesthetics manufacturer Croma-Pharma has entered a licensing agreement with dermatology company Crescita Therapeutics for the rights to Pliaglis.
Aesthetics manufacturer Croma-Pharma has launched new skincare brand ‘Croma farewell’.
We bring you the most up-to-date information for the Aesthetics community across a variety of media, including; news, webinars, podcasts, the Journal, reports, interviews and more!
aesthetics Journal
The Aesthetics Journal is the leading monthly publication for the medical aesthetics specialty. It is peer reviewed and spans an incredible volume of topics. Become a member today to receive the monthly print and digital Journal.
0203 096 1228
2nd Floor, Regal House, 70 London Road
Twickenham TW1 3QS, United Kingdom
© 2023 Easyfairs UK Ltd | Registered in England No. 05067979